Novo has a drug called CagriSema, which is a dual ingredient project product, both the GLP-1 and amylin analog, weekly injectable, potentially approvable in 2027. The next two drugs I'll hit will be ...

In March 2025, the company announced a $2.3bn licensing agreement to acquire global rights to the long-acting amylin analogue, GUB014295, from Danish biotech Gubra. Give your business an edge with our ...

The meteoric rise of the drug semaglutide (marketed as Ozempic or Wegovy) seemed at first to promise an end to dieting. Semaglutide was developed to mimic the multifunctional hormone glucagon-like ...

AMSTERDAM, April 7, 2025 (WAFA) – The Dutch government announced on Monday that it will tighten restrictions on the export of all military products and dual-use goods to Israel. In a letter to ...

RAMALLAH, April 6, 2025 (WAFA) – A 14-year-old Palestinian child was killed and two others were injured by Israeli occupation gunfire on Sunday evening near the town of Turmus Ayya, northeast of ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be ...

2 Numerous multireceptor agonists harnessing the physiological effects of gut hormones, particularly GLP-1, GIP, glucagon, and amylin, are now available or in clinical development for type 2 diabetes ...